首页|期刊导航|中国实验方剂学杂志|EtD框架要点解读及在《中成药药物警戒指南》编制中的应用

EtD框架要点解读及在《中成药药物警戒指南》编制中的应用OA

Interpretation of Evidence-to-decision Framework and Its Application in Pharmacovigilance Guidelines of Chinese Patent Medicines

中文摘要英文摘要

该研究旨在以《中成药药物警戒指南》编制过程为例,解读证据到决策(EtD)框架,详析其在中医药指南研制中的应用要点,为中医药类指南规范化提供方法学参考.研究基于EtD框架提出问题、评价证据、形成推荐意见的核心三阶段,结合《中成药药物警戒指南》的编制目的、范围及主要问题,梳理证据转化过程中的关键决策节点与评价证据,采用名义小组法等质性研究方法形成推荐意见,结果显示在提出问题阶段明确了中成药药物警戒的特殊性与实践需求、聚焦全生命周期安全保障核心目标,评价证据阶段整合政策文件、文献研究、专家共识等多源证据并完成证据评价,形成推荐意见阶段将分散的研究证据与专家经验凝聚为共识,经广泛征求意见与同行评价完成指南研制.研究表明EtD框架可为中医药类指南研制中证据到决策提供结构化工具,有效提升指南研制的透明性与科学性,建议中医药类指南研制参考EtD框架,以完善符合中医药特色的从证据到决策过程.

To interpret the evidence-to-decision(EtD)framework and to illustrate its application in traditional Chinese medicine(TCM)guideline development using the example of the Pharmacovigilance Guideline of Chinese Patent Medicine,thereby providing methodological references for TCM guideline standardization.Based on the core three stages of the EtD framework(formulating the question,making an assessment of the evidence,and drawing conclusions),critical decision points and evaluation evidence within the evidence-translation process were systematically addressed,aligning with the purpose,scope,and key questions of the guideline.Qualitative research methods,such as the nominal group technique,were employed to formulate recommendations.The analysis was conducted based on the EtD framework.During question formulation,the specific characteristics and practical needs of pharmacovigilance for Chinese patent medicines were clarified,focusing on the core objective of safety assurance throughout the product lifecycle.In the evidence assessment,multi-source evidence was integrated,including policy documents,literature research,and expert consensus,completing the evidence evaluation.Finally,in recommendation-forming,dispersed research evidence and expert experience were synthesized into consensus,culminating in the guideline's completion through solicitation of opinions and peer review.The EtD framework provides a structured tool for evidence-to-decision translation in TCM guideline development,effectively enhancing the transparency and scientific rigor of the process.Therefore,it is recommended that TCM guideline development adopt the EtD framework to improve the evidence-to-decision process with TCM characteristics.

张宏艳;马睿;谢雁鸣;王连心;崔鑫;黎元元;王志飞;王萌萌;杨硕;赵晓晓;刘福梅;王雅星

中国中医科学院中医临床基础医学研究所,北京 100700中国中医科学院中医临床基础医学研究所,北京 100700中国中医科学院中医临床基础医学研究所,北京 100700中国中医科学院中医临床基础医学研究所,北京 100700中国中医科学院中医临床基础医学研究所,北京 100700中国中医科学院中医临床基础医学研究所,北京 100700中国中医科学院中医临床基础医学研究所,北京 100700中国中医科学院中医临床基础医学研究所,北京 100700中国中医科学院中医临床基础医学研究所,北京 100700中国中医科学院中医临床基础医学研究所,北京 100700||山东中医药大学附属医院,济南 250014中国中医科学院中医临床基础医学研究所,北京 100700中国中医科学院中医临床基础医学研究所,北京 100700

医药卫生

证据到决策(EtD)框架药物警戒指南证据决策

evidence-to-decision frameworkpharmacovigilanceguidelineevidencedecision

《中国实验方剂学杂志》 2026 (8)

220-228,9

国家重点研发计划"中医药现代化研究"项目(2022YFC3502004)2024年度中国中医科学院中药监管科学研究项目"中西药联合用药风险预警信号检测方法研究"(中央级公益性科研院所基本科研业务费专项)(ZYJGKX202407)国家药品监督管理局"中药临床用药风险评估处置方法与应用研究"项目(RS2024Z008)国家自然科学基金面上项目(81973982)

10.13422/j.cnki.syfjx.20260894

评论